Expressive writing interventions in cancer patients: a systematic review
Expressive writing interventions in cancer patients: a systematic review
复制标题
DOI：
10.1080/17437199.2014.882007
复制
发表时间：
2014-07-03
影响因子：
9.8
通讯作者：
Malcarne, Vanessa L.
中科院分区：
文献类型：
--
作者：
Merz, Erin L.;Fox, Rina S.;Malcarne, Vanessa L.
数十年的研究表明，在受控实验室实验中，表达性写作对健康大学生产生身心益处。这项工作已扩展到临床和医疗人群，包括癌症患者。尽管表达性写作对于这一人群来说可能是一种有前途且廉价的干预措施，但其效果尚未在肿瘤学样本中得到系统检验。使用 PRISMA 指南对参与表达性写作干预的癌症患者的实验试验进行了系统评价。在 PsycINFO 和 PubMed/Medline 上搜索了同行评审的研究。十三篇文章符合纳入/排除标准。尽管大多数干预效果都是无效的，但表达性写作对睡眠、疼痛以及一般身体和心理症状有几个主要影响。确定了几位主持人，表明根据个人特征（例如社会限制），表达性写作可能或多或少有益。由于样本的代表性、性能、检测和患者报告的结果偏差以及干预方案和写作提示的异质性，所审查的研究是有限的。未来需要进行严格设计的研究来确定表达性写作对癌症患者是否具有治疗效果。
Decades of research have suggested that expressive writing produces physical and psychological benefits in controlled laboratory experiments among healthy college students. This work has been extended to clinical and medical populations, including cancer patients. Although expressive writing could be a promising and inexpensive intervention for this population, the effects have not been systematically examined in oncology samples. A systematic review using PRISMA guidelines was conducted for experimental trials of cancer patients who participated in an expressive writing intervention. PsycINFO and PubMed/Medline were searched for peer-reviewed studies. Thirteen articles met the inclusion/exclusion criteria. Although the majority of the intervention effects were null, there were several main effects for expressive writing on sleep, pain, and general physical and psychological symptoms. Several moderators were identified, suggesting that expressive writing may be more or less beneficial based on individual characteristics such as social constraints. The reviewed studies were limited due to representativeness of the samples, performance, detection and patient-reported outcomes biases, and heterogeneity of the intervention protocol and writing prompts. Future studies with rigorous designs are needed to determine whether expressive writing is therapeutically effective in cancer patients.